Structure and activity of membrane receptors: modeling and computational simulation of ligand recognition in a three-dimensional model of the 5-hydroxytryptamine1A receptor

Journal of Biomedical Science

Volumn 3, Issue 2, 1996, Pages 98-107

  Pardo, Leonardo ^a  

^a Department of Physiology and Biophysics ^*

Author keywords

Agonist binding; Antagonist binding; Drug design; Molecular dynamics; Signal transduction

Indexed keywords

EID: 0029906258     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255537     Document Type: Article

References (23)

1. 1a receptor gene. J Biol Chem 265:5825-5832;1990.
2. Arvidsson L-E, Karlen A, Norinder U, Kenne L, Sundell S, Hacksell U. Structural factors of importance for 5-hydroxytryptaminergic activity: Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propyl-amino)tetralin(8-OH-DPAT) and some related agents. J Med Chem 31:212-221;1988.
3. Baldwin JM. The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-1703;1993.
4. Baldwin JM. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol 6:180-190;1994.
5. Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G-protein-coupled receptors. Methods Neurosci 25:366-428;1995.
6. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4:187-217;1983.
7. Burley SK, Petsko GA. Weakly polar interactions in proteins. Adv Protein Chem 39:125-188;1988.
8. 1A serotonin receptor. Mol Pharmacol 43:516-520;1993.
9. 1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol 39:780-787;1991.
10. Dewar MJS, Zoebish EG, Healy EF, Stewart JJP. AM1: A new general purpose quantum mechanical molecular model. J Am Chem Soc 107:3902-3909;1985.
11. Dixon RAF, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD. Structural features required for ligand binding to the β-adrenergic receptor. EMBO J 6:3269-3275;1987.
12. 2-adrenergic receptor. Biochemistry 29:2335-2342;1990.
13. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60:653-688;1991.
14. 1a receptor. Nature 335:358-360;1988.
15. Findlay J, Eliopoulos E. Three-dimensional modeling of G protein-linked receptors. Trends Pharmacol Sci 11:492-499;1990.
16. 1A receptor antagonists: Utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:441-448;1993.
17. Fong TM, Cascieri MA, Yu H, Bansal A, Swain C, Strader CD. Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature 362:350-353;1993.
18. Frisch MJ, Head-Gordon M, Trucks GW, Foresman JB, Schlegel HB, Raghavachari K, Robb MA, Binkley JS, Gonzalez C, Defrees DJ, Fox DJ, Whiteside RA, Seeger R, Melius CF, Baker J, Martin RL, Kahn LR, Stewart JJP, Topiol S, Pople JA, Gaussian 90. Pittsburgh, Gaussian, Inc., 1990.
19. Glennon RA, Westkaemper RB, Bartyzel P. Medicinal chemistry of serotonergic agents. In: Peroutka SJ, ed. Serotonin Receptor Subtypes: Basic and Clinical Aspects. New York, Wiley-Liss, 19-64;1991.
20. 1A receptors. Mol Pharmacol 41:695-698;1992.
21. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J MOl Biol 213:899-929;1990.
22. Ho BY, Karschin A, Branchek T, Davidson N, Lester HA. The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1a receptor: A site-directed mutation study. FEBS Lett 312:259-262;1992.
23. Jäckle H, Luisi PL. Conformational study of histidine- and tryptophan-containing peptides in solution based upon the combination of nuclear magnetic resonance, circular dichroism, and fluorescence measurements. J Phys Chem 88:1767-1777;1984.